Year |
Citation |
Score |
2023 |
Araujo VG, Dias MS, Hauswirth WW, Linden R, Petrs-Silva H. rAAV-compatible human mini promoters enhance transgene expression in rat retinal ganglion cells. Experimental Eye Research. 239: 109758. PMID 38123011 DOI: 10.1016/j.exer.2023.109758 |
0.637 |
|
2023 |
Vasconcelos CFM, Ribas VT, Petrs-Silva H. Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues. Cells. 12. PMID 37681887 DOI: 10.3390/cells12172155 |
0.711 |
|
2023 |
Chiarini LB, Petrs-Silva H, Linden R. Novel approaches to glaucomatous neurodegeneration, based on the integrated stress response. Molecular Therapy. Nucleic Acids. 33: 845-847. PMID 37662966 DOI: 10.1016/j.omtn.2023.08.022 |
0.716 |
|
2022 |
Dias MS, Luo X, Ribas VT, Petrs-Silva H, Koch JC. The Role of Axonal Transport in Glaucoma. International Journal of Molecular Sciences. 23. PMID 35409291 DOI: 10.3390/ijms23073935 |
0.74 |
|
2022 |
Lani-Louzada R, Abreu CA, Araújo VG, Dias MS, Petrs-Silva H, Linden R. Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents. Journal of Visualized Experiments : Jove. PMID 35253788 DOI: 10.3791/63442 |
0.568 |
|
2022 |
Lani-Louzada R, Marra C, Dias MS, de Araújo VG, Abreu CA, Ribas VT, Adesse D, Allodi S, Chiodo V, Hauswirth W, Petrs-Silva H, Linden R. Neuroprotective Gene Therapy by Overexpression of the Transcription Factor MAX in Rat Models of Glaucomatous Neurodegeneration. Investigative Ophthalmology & Visual Science. 63: 5. PMID 35103748 DOI: 10.1167/iovs.63.2.5 |
0.76 |
|
2021 |
Nascimento-Dos-Santos G, de-Souza-Ferreira E, Linden R, Galina A, Petrs-Silva H. Mitotherapy: Unraveling a Promising Treatment for Disorders of the Central Nervous System and Other Systemic Conditions. Cells. 10. PMID 34359994 DOI: 10.3390/cells10071827 |
0.524 |
|
2021 |
Victorino PH, Marra C, Iacobas DA, Iacobas S, Spray DC, Linden R, Adesse D, Petrs-Silva H. Retinal Genomic Fabric Remodeling after Optic Nerve Injury. Genes. 12. PMID 33799827 DOI: 10.3390/genes12030403 |
0.774 |
|
2021 |
Lani-Louzada R, Dias MS, Linden R, de Toledo Ribas V, Petrs-Silva H. Gene Therapy Strategies for Glaucomatous Neurodegeneration. Current Gene Therapy. PMID 33573569 DOI: 10.2174/1566523221666210126152000 |
0.637 |
|
2020 |
Nascimento-Dos-Santos G, de-Souza-Ferreira E, Lani R, de Faria CC, Araujo VG, Teixeira-Pinheiro LC, de Souza Vasconcelos T, Leandro TG, Santiago MF, Linden R, Galina A, Petrs-Silva H. Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165686. PMID 31953215 DOI: 10.1016/J.Bbadis.2020.165686 |
0.604 |
|
2019 |
Lani R, Dias MS, Abreu CA, Araújo VG, Gonçalo T, Nascimento-Dos-Santos G, Dantas AM, Allodi S, Fiorani M, Petrs-Silva H, Linden R. A subacute model of glaucoma based on limbal plexus cautery in pigmented rats. Scientific Reports. 9: 16286. PMID 31705136 DOI: 10.1038/S41598-019-52500-2 |
0.632 |
|
2019 |
Dias MS, Araujo VG, Vasconcelos T, Li Q, Hauswirth WW, Linden R, Petrs-Silva H. Retina transduction by rAAV2 after intravitreal injection: comparison between mouse and rat. Gene Therapy. PMID 31562387 DOI: 10.1038/S41434-019-0100-9 |
0.623 |
|
2019 |
Nascimento-Dos-Santos G, Teixeira-Pinheiro LC, da Silva-Júnior AJ, Carvalho LRP, Mesentier-Louro LA, Hauswirth WW, Mendez-Otero R, Santiago MF, Petrs-Silva H. Effects of a combinatorial treatment with gene and cell therapy on retinal ganglion cell survival and axonal outgrowth after optic nerve injury. Gene Therapy. PMID 31243393 DOI: 10.1038/S41434-019-0089-0 |
0.428 |
|
2018 |
Lopes-Pacheco M, Kitoko JZ, Morales MM, Petrs-Silva H, Rocco PRM. Self-complementary and tyrosine-mutant rAAV vectors enhance transduction in cystic fibrosis bronchial epithelial cells. Experimental Cell Research. PMID 30244179 DOI: 10.1016/J.Yexcr.2018.09.015 |
0.344 |
|
2017 |
Cabral-Miranda F, Nicoloso-Simões E, Adão-Novaes J, Chiodo V, Hauswirth WW, Linden R, Chiarini LB, Petrs-Silva H. rAAV8-733-Mediated Gene Transfer of CHIP/Stub-1 Prevents Hippocampal Neuronal Death in Experimental Brain Ischemia. Molecular Therapy : the Journal of the American Society of Gene Therapy. 25: 392-400. PMID 28153090 DOI: 10.1016/J.Ymthe.2016.11.017 |
0.743 |
|
2016 |
Martini SV, Silva AL, Ferreira D, Rabelo R, Ornellas FM, Gomes K, Rocco PR, Petrs-Silva H, Morales MM. Tyrosine Mutation in AAV9 Capsid Improves Gene Transfer to the Mouse Lung. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 39: 544-553. PMID 27384068 DOI: 10.1159/000445646 |
0.311 |
|
2014 |
Cabral Miranda F, Adão-Novaes J, Hauswirth WW, Linden R, Petrs-Silva H, Chiarini LB. CHIP, a carboxy terminus HSP-70 interacting protein, prevents cell death induced by endoplasmic reticulum stress in the central nervous system. Frontiers in Cellular Neuroscience. 8: 438. PMID 25620910 DOI: 10.3389/Fncel.2014.00438 |
0.739 |
|
2014 |
Petrs-Silva H, Linden R. Advances in gene therapy technologies to treat retinitis pigmentosa. Clinical Ophthalmology (Auckland, N.Z.). 8: 127-36. PMID 24391438 DOI: 10.2147/Opth.S38041 |
0.628 |
|
2013 |
Petrs-Silva H, Linden R. Advances in recombinant adeno-associated viral vectors for gene delivery. Current Gene Therapy. 13: 335-45. PMID 24060313 DOI: 10.2174/15665232113136660028 |
0.568 |
|
2012 |
Petrs-Silva H, Yasumura D, Matthes MT, LaVail MM, Lewin AS, Hauswirth WW. Suppression of rds expression by siRNA and gene replacement strategies for gene therapy using rAAV vector. Advances in Experimental Medicine and Biology. 723: 215-23. PMID 22183336 DOI: 10.1007/978-1-4614-0631-0_29 |
0.421 |
|
2011 |
Petrs-Silva H, Dinculescu A, Li Q, Deng WT, Pang JJ, Min SH, Chiodo V, Neeley AW, Govindasamy L, Bennett A, Agbandje-McKenna M, Zhong L, Li B, Jayandharan GR, Srivastava A, et al. Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 293-301. PMID 21045809 DOI: 10.1038/Mt.2010.234 |
0.361 |
|
2009 |
Martini SV, Fagundes SS, Schmidt AC, Avila M, Ornellas DS, Ribas VT, Petrs-Silva H, Linden R, Faffe DS, Guggino SE, Rocco PR, Zin WA, Morales MM. Does the use of recombinant AAV5 in pulmonary gene therapy lead to lung damage? Respiratory Physiology & Neurobiology. 168: 203-9. PMID 19573627 DOI: 10.1016/J.Resp.2009.06.016 |
0.736 |
|
2009 |
Petrs-Silva H, Dinculescu A, Li Q, Min SH, Chiodo V, Pang JJ, Zhong L, Zolotukhin S, Srivastava A, Lewin AS, Hauswirth WW. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 463-71. PMID 19066593 DOI: 10.1038/Mt.2008.269 |
0.393 |
|
2008 |
Petrs-Silva H, Chiarini LB, Linden R. Nuclear proteasomal degradation and cytoplasmic retention underlie early nuclear exclusion of transcription factor Max upon axon damage. Experimental Neurology. 213: 202-9. PMID 18601921 DOI: 10.1016/J.Expneurol.2008.06.001 |
0.761 |
|
2008 |
Lassance RM, Pássaro CP, Martini SV, Castiglione RC, Gutierrez TM, Abreu SC, Antunes MA, Xisto DG, Cebotaru L, Petrs-Silva H, Zin WA, Guggino WB, Linden R, Rocco PR, Morales MM. Does the use of recombinant AAV2 in pulmonary gene therapy damage lung function? Respiratory Physiology & Neurobiology. 160: 91-8. PMID 17950048 DOI: 10.1016/J.Resp.2007.09.002 |
0.547 |
|
2005 |
Petrs-Silva H, Chiodo V, Chiarini LB, Hauswirth WW, Linden R. Modulation of the expression of the transcription factor Max in rat retinal ganglion cells by a recombinant adeno-associated viral vector. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas MéDicas E BiolóGicas / Sociedade Brasileira De BiofíSica ... [Et Al.]. 38: 375-9. PMID 15761617 DOI: 10.1590/S0100-879X2005000300008 |
0.784 |
|
2004 |
Pinto DO, Ferreira PL, Andrade LR, Petrs-Silva H, Linden R, Abdelhay E, Araújo HM, Alonso CE, Pavão MS. Biosynthesis and metabolism of sulfated glycosaminoglycans during Drosophila melanogaster development. Glycobiology. 14: 529-36. PMID 15044397 DOI: 10.1093/Glycob/Cwh070 |
0.5 |
|
2004 |
Petrs-Silva H, de Freitas FG, Linden R, Chiarini LB. Early nuclear exclusion of the transcription factor max is associated with retinal ganglion cell death independent of caspase activity. Journal of Cellular Physiology. 198: 179-87. PMID 14603520 DOI: 10.1002/Jcp.10404 |
0.774 |
|
2000 |
Chiarini LB, Freitas FG, Petrs-Silva H, Linden R. Evidence that the bifunctional redox factor / AP endonuclease Ref-1 is an anti-apoptotic protein associated with differentiation in the developing retina. Cell Death and Differentiation. 7: 272-81. PMID 10745272 DOI: 10.1038/Sj.Cdd.4400639 |
0.77 |
|
Show low-probability matches. |